TY - JOUR
T1 - Navigating ethical quandaries with the privacy dilemma of biomedical datasets
AU - Görsoy, Gamze
AU - Doerr, Megan
AU - Wilbanks, John
AU - Wagner, Jennifer K.
AU - Tang, Haixu
AU - Brenner, Steven E.
N1 - Funding Information:
* This work is partially supported by NIH grant U01EB023686. † This work is partially supported by NIH grant U01EB023686, U41HG007346 and Tata Consultancy Service © 2019 The Authors. Open Access chapter published by World Scientific Publishing Company and distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC) 4.0 License.
Publisher Copyright:
© 2019 The Authors.
PY - 2020
Y1 - 2020
N2 - With decreasing cost of biomedical technologies, the scale of the genetic and healthcare data have exponentially increased and become available to wider audiences. Hence, privacy of patients and study participants has garnered the attention of researchers and regulators alike. Availability of genetic and health care information for uses not anticipated at the time of collection gives rise to privacy concerns such that people suffer dignitary harm when their data is used in ways they did not desire or intend, even if no concrete economic damage results. In this workshop, we explore the issues surrounding data use to advance human health from a privacy perspective. Broadly this field can be considered in two encompassing areas: (1) Ethics and regulation of privacy: The ethical and regulatory frames through which we can consider privacy, the existing regulations regarding privacy and what is on the horizon, and implementation of such ethical considerations for data with the new Common Rule. (2) Approaches to ensuring privacy using technology: The technologies that allow responsible use and sharing of data such as encryption and the quantification of privacy leakages in publicly available data through privacy attacks for better risk-Assessment tools.
AB - With decreasing cost of biomedical technologies, the scale of the genetic and healthcare data have exponentially increased and become available to wider audiences. Hence, privacy of patients and study participants has garnered the attention of researchers and regulators alike. Availability of genetic and health care information for uses not anticipated at the time of collection gives rise to privacy concerns such that people suffer dignitary harm when their data is used in ways they did not desire or intend, even if no concrete economic damage results. In this workshop, we explore the issues surrounding data use to advance human health from a privacy perspective. Broadly this field can be considered in two encompassing areas: (1) Ethics and regulation of privacy: The ethical and regulatory frames through which we can consider privacy, the existing regulations regarding privacy and what is on the horizon, and implementation of such ethical considerations for data with the new Common Rule. (2) Approaches to ensuring privacy using technology: The technologies that allow responsible use and sharing of data such as encryption and the quantification of privacy leakages in publicly available data through privacy attacks for better risk-Assessment tools.
UR - http://www.scopus.com/inward/record.url?scp=85075993582&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85075993582&partnerID=8YFLogxK
M3 - Conference article
C2 - 31797643
AN - SCOPUS:85075993582
SN - 2335-6928
VL - 25
SP - 736
EP - 738
JO - Pacific Symposium on Biocomputing
JF - Pacific Symposium on Biocomputing
IS - 2020
T2 - 25th Pacific Symposium on Biocomputing, PSB 2020
Y2 - 3 January 2020 through 7 January 2020
ER -